Court ruling favors GenSpera in U.S. patent dispute
By Peggy O’Harehttp://www.mysanantonio.com/ http://stockpumpers.blogspot.com/2014/11/court-ruling-favors-genspera-in-us.html
SAN ANTONIO — A San Antonio company developing prodrug therapeutics to treat cancer said Thursday that a federal court ruled in its favor in a patent dispute.
GenSpera Inc. said it welcomed the Sept. 12 decision by a U.S. District Court in Maryland, which essentially dismisses Dr. Annastasiah Mhaka’s claims that she was wrongly omitted from two of the company’s U.S. patents for its lead drug candidate, mipsagargin.
Mhaka had worked as a post-graduate student for two of GenSpera’s founders who obtained the patents, Johns Hopkins University professors Samuel Denmeade and John Isaacs. Mhaka claimed she should have been credited as a co-inventor of the pharmaceutical. The company denied that.
“Our defense against these claims has demonstrated GenSpera’s commitment to protecting its technologies and intellectual property portfolio,” CEO Craig Dionne said.